PEPG PepGen

Watchlist

1.940
-0.010-0.51%

Close Jan 24 16:00 ET

1.940
0.0000.00%

Post 20:01 ET

63.24MMarket Cap-0.65P/E (TTM)

About PepGen Company

PepGen Inc. develops oligonucleotide therapies. It is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics with the goal of transforming the treatment of severe neuromuscular and neurologic diseases. The company was founded in March 26, 2018 and is headquartered in Boston, MA.

Company Profile

SymbolPEPG

Company NamePepGen

Listing DateMay 6, 2022

Issue Price12.00

Founded2018

CEOMr. James McArthur, PhD

MarketNASDAQ

Employees64

Fiscal Year Ends12-31

Address321 Harrison Avenue,8th Floor

CityBoston

ProvinceMassachusetts

CountryUnited States of America

Zip Code02118

Phone1-781-797-0979

Websitehttp://pepgen.com

Company Executives

Name
Position
Salary

James McArthur, PhD
President, Chief Executive Officer and Director
3.43M

Noel Donnelly, M.B.A.
Chief Financial Officer and Principal Accounting Officer
1.97M

Dr. Michelle L. Mellion, M.D.
Senior Vice President, Clinical Development
1.41M

Dr. Niels Svenstrup, PhD
Senior Vice President, Chemistry, Manufacturing and Control
--

Laurie B. Keating, J.D.
Chairman of the Board
154.82K

Heidi Henson, C.P.A.
Independent Director
123.32K

Habib Joseph Dable
Independent Director
90.24K

Dr. Howard Mayer, M.D.
Independent Director
64.16K

Mary Beth DeLena, J.D.
General Counsel and Secretary
--

PEPG PepGen

About PepGen Company

Company Profile

Company Executives

Trending Stocks